Related Experiment Videos
[Can acute disseminated encephalomyelitis progress in a deferred way?]
B Gener1, C Garaizar-Axpe, C Ruiz Espinosa
1Hospital de Cruces, Baracaldo, 48903, España.
Revista De Neurologia
|September 20, 2001
Summary
Acute disseminated encephalomyelitis (ADEM) can present with recurrent symptoms, suggesting a multiphasic course. This case highlights favorable outcomes with combined methylprednisolone and immunoglobulin therapy for recurrent ADEM.
Area of Science:
- Neurology
- Pediatric Neurology
- Immunology
Background:
- Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating disease.
- ADEM typically presents as a monophasic illness, but heterogeneous clinical courses are increasingly recognized.
- Differentiating recurrent ADEM from other demyelinating conditions like multiple sclerosis (MS) is crucial for appropriate management.
Observation:
- A 5-year-old boy experienced two distinct episodes of neurological symptoms separated by several weeks.
- Clinical presentation and magnetic resonance imaging (MRI) findings were consistent with ADEM.
- Cerebrospinal fluid (CSF) analysis showed no oligoclonal bands, aiding in the exclusion of multiple sclerosis (MS).
Findings:
- The recurrent neurological symptoms in this pediatric patient suggest a multiphasic disseminated encephalomyelitis (MDEM).
- The case demonstrates that ADEM can exhibit a multiphasic or relapsing-remitting course.
- Exclusion of MS was based on clinical course, MRI, and CSF findings.
Implications:
- Recognition of MDEM is important for accurate diagnosis and prognosis in pediatric demyelinating diseases.
- Prompt and aggressive treatment, including corticosteroids and immunoglobulins, may lead to favorable outcomes in MDEM.
- This case underscores the importance of considering multiphasic presentations of ADEM in children.